← Back

Tate & Lyle PLC

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company's products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company has a strategic collaboration with BioHarvest Sciences Inc. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

Price · split & dividend adjusted
News & notes moving TATE.LSE
TATE.LSE

Ingredion reaffirms 2026 adjusted EPS of $10.30 to $10.90 while progressing Tate & Lyle deal

Ingredion reaffirmed its full-year 2026 adjusted earnings per share guidance of $10.30 to $10.90, reflecting the sale of its majority stake in the Pakistan business. The company reported second-quarter net sales of $1.85 billion, up 1% from the prior year, with Texture & Healthful Solutions volume growth accelerating to 7%. Ingredion also announced that Tate & Lyle shareholders approved its all-cash offer, and the transaction is expected to deliver $130 million of run-rate synergies by 2030 and greater than 15% adjusted EPS accretion in the first full calendar year post-acquisition. Adjusted operating income for the quarter was $258 million, while cash from operations for the full year is now anticipated to be between $700 million and $800 million. Capital expenditures are expected to range from $450 million to $490 million, with additional spend allocated to the Argo facility.
Seeking Alpha·22dRead more ▾
TATE.LSE2

Pzena Investment Management Discloses 3.56% Stake in Tate & Lyle

Pzena Investment Management, LLC disclosed a 3.56% interest in Tate & Lyle Plc, holding 15,869,502 ordinary 10p shares as of July 20, 2026. The disclosure, made under Rule 8.3 of the Takeover Code, also reported a sale of 97,568 shares at £5.59 per share. No cash-settled or stock-settled derivatives were held, and no indemnity or other dealing arrangements were in place.
Business Wire·37dRead more ▾
TATE.LSE2

Millennium International Management LP discloses 3.437% stake in Tate & Lyle plc

Millennium International Management LP has disclosed a 3.437% interest in Tate & Lyle plc through cash-settled derivatives, according to a regulatory filing dated June 24, 2026. The position, held as of June 23, 2026, comprises 15,311,759 reference securities in the 29 1/6p ordinary shares, with no relevant securities owned directly. The filing details multiple equity swap transactions on June 23, including closing a short position of 1,974,492 shares at 5.54 GBP and opening or increasing long positions totaling 1,679,456 shares at prices of 5.54 and 5.55 GBP. No stock-settled derivatives or other arrangements were reported.
Business Wire·63dRead more ▾
TATE.LSE

Jim Cramer Says Ingredion Will Become an Ingredient Powerhouse After Tate & Lyle Deal

Jim Cramer highlighted Ingredion on Mad Money, arguing the market is overlooking its $3.6 billion cash acquisition of British ingredients company Tate & Lyle. He noted that Ingredion, which makes flavors and textures for the food and beverage industries, has a market capitalization of only $6.2 billion, making this a transformative deal that will create a powerhouse in the ingredients space. Cramer pointed out that the stock is down 10% for the year, partly due to an imperfect quarter in early May, but he believes the merger will make Ingredion the most important company in its industry.
Insider Monkey·67dRead more ▾